Cytogen Company Description

Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea.

The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies.

The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

Cytogen, Inc.

Country	South Korea
Founded	2010
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	56
CEO	Byung-Hee Jeon

Contact Details

Address: SK V1 GL Metrocity Seoul, 05854 South Korea
Phone	82 2 6925 1070
Website	cytogenlab.com

Stock Details

Ticker Symbol	217330
Exchange	Korea Exchange - KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2835

Key Executives

Name	Position
Byung-Hee Jeon	Chief Executive Officer